Start Date
February 29, 2016
Primary Completion Date
April 30, 2018
Study Completion Date
July 31, 2018
Oral treprostinil
Oral treprostinil will be administered as TID dosing for up to 16 Weeks.
CLC Pulmonary Hypertension Clinic Division of Pulmonary, Allergy and Critical Care Medicine UPMC, Pittsburgh
Johns Hopkins University, Baltiomore
Emory University Hospital, Atlanta
Banner University Medical Center Phoenix Advanced Lung Disease, Phoenix
University of California, Los Angeles - Pulmonary Division, Los Angeles
University of California - Davis Medical Group, Sacramento
Oregon Health and Science University, Portland
Lead Sponsor
United Therapeutics
INDUSTRY